TrialJournal of virology1996

Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative Group.

B A Larder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.